Printer Friendly

Fibromyalgia Patients May Be Grouped by Symptom and Severity Level, Informing Therapeutic Decisions, Study Finds.

PHOENIX, March 6, 2014 /PRNewswire-USNewswire/ -- Examining outcome data on fibromyalgia, researchers were able to fit fibromyalgia patients into 1 of 4 symptom domains, each distinguished by greater presence or severity of specific symptoms. The study results, which suggest a step forward for individualized patient therapy, were presented in a scientific poster today at the 30[sup.th] Annual Meeting of the American Academy of Pain Medicine.

Fibromyalgia is a condition marked by many symptoms that include widespread pain, fatigue, depression and sleep disturbances. However, not every fibromyalgia patient experiences every symptom or to the same degree, complicating therapeutic decisions.

"Currently, fibromyalgia is ineffectively treated and heterogeneity is part of the problem," said lead study author, Ann Vincent, MBBS, MD, former medical director and now a fulltime researcher with the Mayo Fibromyalgia Clinic in Rochester, Minn.

"When a patient comes into the clinic, there is no standardized way to classify the heterogeneity in a way to understand their most bothersome symptom. Different physicians have their own ad hoc methods and choices of medications," Dr. Vincent said. "What if we could have a better way to assess patients by classifying the illness from their perspective in terms of their most bothersome symptoms?"

Guided by that research question, study investigators were the first to use core symptom domains recommended by the fibromyalgia working group of the Outcome Measures in Rheumatoid Arthritis Clinical Trials[OMERACT] initiative to identify subgroups of patients with similar symptom profiles. The OMERACT initiative develops and validates outcome measures to assist with research in clinical trials. The Institutional Review Board of the Mayo Clinic approved the study, which was partially funded by grants through the Mayo Clinic and the National Institutes of Health.

"We were looking to cluster participants according to their response to a comprehensive symptom questionnaire package to identify groups of individuals who reported similar symptom profiles," Dr. Vincent said.

Included for analysis were 581 females with a mean age of 55.1, each with a fibromyalgia diagnosis. The patients completed several outcome measures recommended by OMERACT as follows: the Brief Pain Inventory, 30-item Profile of Mood States, Medical Outcomes Sleep Scale, Multidimensional Fatigue Inventory, Multiple Ability Self-Report Questionnaire, Fibromyalgia Impact Questionnaire-Revised and Medical Outcomes Short Form-36.

The study investigators then used a statistical technique that groups or clusters similar observations or values to identify

More...

SOURCE American Academy of Pain Medicine
COPYRIGHT 2014 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2014 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 6, 2014
Words:464
Previous Article:Prescriptions for Benzodiazepines Rising and Risky When Combined with Opioids, Stanford Researchers Warn.
Next Article:Algonquin Power & Utilities Corp. Announces 2013 Fourth Quarter and Year End Financial Results.
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters